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Abstract The yeast MBA1 gene (Multi-copy Bypass of AFG3) 
is one of three genes whose overexpression suppresses afg3-null 
and rcal-null mutations. Bypass of AFG3 and RCA1, whose 
products are essential for assembly of mitochondrial inner 
membrane enzyme complexes, suggests a related role for 
MBA1. The predicted translation product is a 30 kDa 
hydrophilic protein with a putative mitochondrial targeting 
sequence and no homology to any sequence in protein or EST 
databases. Gene disruption leads to a partial respiratory growth 
defect, which is more pronounced at temperatures above 30°C. 
Concomitantly, amounts of cytochromes b and aa3 are reduced. 
A C-terminal c-myc-tagged MBA1 gene product is functional 
and is found associated with the mitochondrial inner membrane, 
from which it can be extracted by carbonate, but not by high salt. 
These observations give further support to a role of MBA1 in 
assembly of the respiratory chain. 
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1. Introduction 
About half of  the proteins of the mitochondrial inner mem- 
brane form part of enzyme complexes involved in oxidative 
phosphorylation [1]. The biogenesis of these complexes re- 
quires regulation of mitochondrial and nuclear gene expres- 
sion, involving a host of nuclear-encoded factors acting at 
different levels [2]. Some of these factors act at a post-transla- 
tional, post-sorting level; these affect assembly of subunits 
into holoenzymes and/or their degradation. The AFG3 
(YTAIO) gene of S. cerevisiae has been implicated in both 
these processes; it is required for degradation of prematurely 
terminated and complete mitochondrial translation products 
[3,4] and for assembly of  complexes III, IV and V [5]. Afg3p 
belongs to the FtsH subgroup of the AAA family of ATPases 
[6,7]. A direct role in protein breakdown of members of this 
subgroup, which contains mitochondrial and prokaryotic 
members, is supported by conserved sequence motifs that sug- 
gest ATP-dependent metallo-endoprotease activity [8]. Such 
an activity has been demonstrated in vitro for E. coli FtsH 
[9]. However, a mutation in the metalloprotease active site 
moti f  of AFG3 that strongly reduces proteolysis does not af- 
fect growth on non-fermentable carbon sources, suggesting 
that the involvement of Afg3p in assembly of enzyme com- 
plexes of the mitochondrial inner membrane is independent of 
its protease activity [4]. 
In an effort to obtain more information on AFG3 function, 
we isolated multi-copy suppressor genes of  an afg3-null muta- 
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tion. By examining the function of genes that can bypass 
AFG3 when overexpressed, we aimed to better define the pri- 
mary defect caused by inactivation of AFG3. One of these 
afg3-null suppressors is MBA1 (Multi-copy Bypass of 
AFG3), whose sequence was identified previously in the yeast 
sequencing project (YBR1307 in [10]), but whose function was 
unknown. Here, we present a further characterization of 
MBA1 and its gene product. Our results suggest that 
MBA1, like AFG3 and RCA1, affects assembly of the respira- 
tory chain of  yeast mitochondria. 
2. Materials and methods 
2.1. Strains of S. cerevisiae and growth media 
The wild-type Saccharomyces c revisiae strains used in this study 
are W303/1A (MATa, ade2-1, his3-11,-15, leu2-3,-112, ura3-1, trpl-1, 
canl-lO0) [11] and D273UK (MATs, met6, ura3, lys2) [12]. DDM1 
(MATer, met6, ura3, lys2, tubal.: URA3) was derived from D273UK 
by disruption of the MBA1 gene with URA3 (see Fig. 2). 
The following media were used for the propagation of yeast: YPD 
(2% glucose, 1% peptone, 1% yeast extract); lactate (1.5% lactic acid, 
2% sodium lactate, 8 mM MgSO4, 45 mM (NH4)~HPO4, 0.5% yeast 
extract); WO (2% glucose, 0.67% yeast nitrogen base without amino 
acids (Difco)). Where required, media were supplemented with nutri- 
tional requirements o the appropriate concentrations. Solid media 
contained 2% agar. 
2.2. Construction fan MBAl-c-myc fusion gene 
For the construction of an MBAl-c-myc fusion gene we made use 
of the vector YEpmycl81 which contains a synthetic -myc epitope 
cloned in the polylinker [13]. Plasmid pJN-C4 contains a 2.9 kb geno- 
mic DNA fragment which includes the MBA1 gene (Rep et al., sub- 
mitted). A 1.75 kb fragment containing MBA1 with an XmaI linker at 
its 3' end was generated by PCR using plasmid pJN-C4 as the tem- 
plate and the following primers: M13 (GTTTTCCCAGTCACGAC) 
and MBA#1 (TAATCCCGGGGGCTTGGAGGTAAACG; Xmal 
linker underlined). This fragment was cut with XmaI and cloned 
into XmaI-linearized YEpmycl 81, yielding pE-MBAcmyc. The correct 
orientation was verified by restriction analysis and the in-frame fusion 
of MBA1 to c-myc oding sequences was confirmed by sequence anal- 
ysis. pC-MBAcmyc was created by subcloning a BamHI-Narl frag- 
ment containing the MBAl-c-myc fusion gene into the low-copy vec- 
tor YCplacl 11. 
2.3. Isolation and fractionation of mitochondria 
Cells were grown until early stationary phase in lactate medium. 
Mitochondria were isolated by lysis of spheroplasted cells in breaking 
buffer (BB; 0.65 M sorbitol, 20 mM KPi pH 7.5, 1 mM MgC12, 1 mM 
EDTA), using a Dounce homogenizer. Unbroken cells and cell debris 
were removed by a low-speed spin (4000 rpm for 5 min in a Sorvall 
SS-34 rotor). Mitochondria were pelleted by a high-speed spin (12 000 
rpm for 10 min), washed once in BB and suspended in BB to a protein 
concentration of 10 mg/ml. Before application on gel, mitochondrial 
proteins were always precipitated with trichloroacetic a id (TCA) and 
resuspended in Laemmli sample buffer (LSB) [14]. Proteins in the 
supernatant from the high-speed spin were precipitated with TCA 
and resuspended in LSB; this is the cytoplasmic fraction. To fraction- 
ate mitochondria into membrane and soluble fractions, they were 
suspended in 10 mM Tris-HC1 pH 7.4, 1 mM EDTA and sonicated 
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6 times for 5 s at 0°C, followed by centrifugation at 165 000 ×g for 60 
min in a Beckman type SW50.1 rotor. Pellet and supernatant repre- 
sent the membrane and soluble fractions, respectively. Alternatively, 
mitochondria were pelleted and resuspended in 0.1 M NaCO3 to a 
protein concentration of 1 mg/ml and left on ice for 45 min with 
occasional vortexing. Membrane and soluble fractions were separated 
as above. A mix of protease inhibitors (1 mM PMSF, 1 mM EDTA, 
2 ~tg/ml pepstatin, 2 ~tg/ml chymostatin) was added before fractiona- 
tion of mitochondria to avoid protein breakdown. 
Mitoplasts were obtained by diluting the mitochondrial suspension 
3.25-fold in 20 mM Tris-HC1 pH 7.5, leaving the suspension for 10 
min on ice, and sedimenting the mitoplasts at 15 000 rpm for 15 min 
in a Heraeus Sepatech Biofuge 17RS. For treatment with proteinase 
K (0.33 mg/ml; 30 min at 0°C), mitochondria or mitoplasts were 
suspended in BB to a protein concentration of 5 mg/ml. After TCA 
precipitation, samples corresponding to 75 ~tg of mitochondrial pro- 
tein were applied on gel. 
2.4. Western blot analysis 
Protein electrophoresis was carried out according to Laemmli [14]. 
HRP-conjugated secondary antibodies were used for immunoblotting 
as described in the Promega Protocols and Applications Guide, sec- 
ond edition, 1991. A monoclonal antibody for detection of the human 
c-myc epitope was obtained form ICI, Cambridge Biochemicals (clone 
9El0). Polyclonal antibodies raised against hexokinase, the mitochon- 
drial ADP/ATP carrier and the [3 subunit of ATP synthase were used. 
2.5. Miscellaneous 
Standard methods were used for manipulation of DNA, transfor- 
mation of E. coli (strain DH5ct) and Southern blotting [15]. Trans- 
formation of yeast cells was done according to [16], DNA sequence 
analysis by the method of Sanger [17]. 
3. Results 
3.1. Characterization of an MBAl-disruption strain 
The MBA1 gene was isolated as a multi-copy suppressor of 
the respiratory growth defect caused by an afg3-null mutation. 
The gene also suppresses real-null and afg3/rcal double mu- 
tations (data not shown). MBA1 encodes a putative 278 ami- 
no acid protein whose N-terminal sequence has all the char- 
acteristics of cleavable mitochondrial targeting sequences [10] 
(Fig. 1). The PSORT program [18] yields the mitochondrial 
matrix as the location of highest probability (cer- 
tainty = 0.807) and does not list any non-mitochondrial loca- 
lization. To date, no sequences resembling MBA1 have been 
found in any database xamined (checked using XDBRef  [19] 
and Fastalert (Biocomputing Basel)). To learn more about its 
function, MBA1 was disrupted by insertion of a 1.1 kb DNA 
fragment containing the URA3 gene into the BgllI site close 
to the 5' end of the open reading frame (Fig. 2). The possi- 
bility that the remaining coding sequence is expressed into a 
functional protein is highly unlikely since the first ATG that 
could serve to initiate translation is codon 183. Moreover, we 
have seen that even short N- or C-terminal truncations lead to 
loss of afg3-null suppressor activity (Rep, unpublished obser- 
vations). The disruption construct was used to inactivate 
MBA1 in the wild-type strain D273UK. The resulting strain 
Table 1 
Generation times of D273UK (wild-type) 
(tubal:: URA3) with lactate as carbon source 
and DDM 1 
Generation time (h) 
at 30°C at 35°C 
D273UK 2.5 3.2 
DDM 1 3.5 5.7 
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Fig. l. Sequence characteristics of the Mbal protein. Mbalp is a 
278 amino acid protein (panel A) with a putative mitochondrial tar- 
geting sequence (cleavage sites predicted by PSORT [18] are indi- 
cated by arrowheads). The acidic and basic amino acid side chain 
map (panel B; A: acidic side chains, B: basic side chains) and hy- 
dropathy profile according to Kyte and Doolittle (panel C; high 
values indicate hydrophobic regions) were generated with DNA Stri- 
der (C. Marck, CEA-FRANCE). The most obvious feature beside 
the putative mitochondrial targeting sequence is a very hydrophilic 
region of 22 amino acids following the putative targeting sequence 
(indicated with bold in panel A). The c-myc epitope present in 
Mbal-cmyc is indicated by italics in panel A. 
shows a reduced growth rate on non-fermentable carbon 
sources, which is more pronounced at high temperature (Ta- 
ble 1). This correlates with reduced levels of cytochromes b
and aa3 in mitochondria isolated from the tubal: : URA3 
strain (Fig. 3), indicating that Mba lp  is involved in biogenesis 
of respiratory chain complexes. Cytochrome aa3 is more sen- 
sitive to growth at 35°C than cytochrome b. Cytochrome c 
oxidase levels may therefore be limiting for respiratory growth 
at this temperature. 
3.2. Epitope-tagged Mbalp localizes to the mitoehondrial inner 
membrane 
For determination of the subcellular location of Mbalp,  a 
c-myc epitope was added to its C-terminus, allowing visuali- 
zation of the fusion protein with anti-c-myc antibody (see 
Section 2). Mbal -cmyc is likely to have the same location as 
Mbalp,  as it suppresses equally well the afg3-null mutation 
(not shown). Yeast strains transformed with either a high or 
low copy number plasmid encoding Mbal -cmyc contain a 
protein of 30 kDa in the mitochondrial fraction that is recog- 
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nized by the anti-c-myc antibody (Fig. 4A). This corresponds 
to the predicted size of Mbal-cmyc (33.3 kDa) minus a puta- 
tive cleavable presequence of about 3 kDa. 
As detection in strains carrying a low copy MBA1 plasmid 
was difficult, we proceeded with the strain carrying the high 
copy MBA1 plasmid to identify the submitochondrial location 
of Mbal-cmyc. Fig. 4B shows that Mbal-cmyc is present in 
the membrane fraction upon sonication of mitochondria, nd 
can only be extracted from the membrane with carbonate, but 
not with NaC1 in concentrations up to 1 M. Even with car- 
bonate, part of Mbal-cmyc remains in the membrane frac- 
tion, while the Fll] subunit of ATP synthase is completely 
solubilized (Fig. 4B, last 2 lanes). Furthermore, Mbal-cmyc 
was protected in mitoplasts from externally added proteinase 
K, under conditions where the ADP/ATP carrier (AAC2) is 
sensitive to proteolysis (Fig. 4C). The fact that most Mbal- 
cmyc was extracted with carbonate precludes a transmem- 
brane topology, in line with the absence from the sequence 
of a hydrophobic region of sufficient length to span the mem- 
brane (Fig. 1). We conclude that Mbalp is firmly attached to 
the inner side of the mitochondrial inner membrane when 
expressed from a multi-copy plasmid; the condition under 
which it is active as a suppressor of afg3-null. In view of the 
effect of Mbalp depletion on the levels of inner membrane 
complexes, this location is in agreement with its presumed site 
of action under normal conditions. However, we cannot ex- 
clude the possibility that overproduction f Mbalp influences 
its location, for example by inducing membrane association. 
4. Discussion 
We show here that MBA1, a multi-copy suppressor of afg3- 
null, encodes a mitochondrial protein of about 30 kDa that is 
required for biogenesis of the respiratory chain. As mitochon- 
drial protein synthesis i  not affected in an MBA1 disruption 
strain (not shown), Mbalp is likely to act post-translationally. 
Thus, it can be added to the list of proteins that act at a post- 
translational level in the assembly of mitochondrial inner 
membrane complexes, where it falls within the category of 
factors that affect the assembly of more than one complex 
[2]. Other proteins in this category are MRS2 [20], OXA1 
HindIII 
NheI HpaI BglII BamHI 
URA3 
I I 
1.0 kb 
Fig. 2. Disruption of MBA1. The MBA1 gene, present on a 2.9 kb 
genomic DNA fragment in pUC18, was disrupted by insertion of a 
1.2 kb URA3 fragment from pf138 into the BglII site near the 5' 
end of the open reading frame. Transformation of the linearized 
construct o wild-type strain D273UK yielded DDM1 (et, rnet6, 
ura3, lys2, rnbal : : URA3). 
absorbance 
D273 28"C 
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Fig. 3. Spectral analysis of mitochondria from wild-type and 
tubal: : URA3 cells. Mitochondria isolated from cells grown in Lac 
medium at either 28°C or 35°C were suspended in 100 mM KP~ pH 
7.4, 250 mM sucrose, 0.5% cholate to a protein concentration f 2- 
4 mg/ml. Difference spectra were recorded at room temperature 
with an Aminco DW2000 spectrophotometer after oxidizing one 
half of the suspension with ferricyanide and reducing the other half 
with sodium dithionite. Cytochrome c and cl absorb maximally at 
550 nm, cytochrome b at 562 nm and cytochrome a and a3 at 605 
nm. D273: wild-type (D273UK), DDM1 : mutant (mbal: URA3). 
[21,22], AFG3, RCA1 [5] and YME1 [23,24]. The latter three 
belong to the same subfamily of the AAA family of ATPases 
[6,7] with (putative) ATP-dependent metalloprotease activity 
(see Section 1). Interestingly, as a rule, complex IV is more 
affected than complex III in strains mutated for either of the 
above genes. Like YME1, MBA1 is more important for re- 
spiratory growth at high temperature. 
Although the exact molecular function of Mbalp has yet to 
be resolved, our finding that Mbalp can associate with the 
matrix side of the inner membrane is consistent with a direct 
involvement in assembly processes. A similar function has 
been proposed for OXA1, which was also found as a multi- 
copy suppressor of afg3- and real-null mutations (Rep et al., 
manuscript in preparation). Disruption of OXA1 leads to sev- 
eral mitochondrial defects: loss of cytochrome aa3 and reduc- 
tion of cytochrome b, an RNA splicing and/or stability defect 
[21], a block in processing of CoxII and an overall reduction 
of mitochondrial biogenesis [22]. In contrast to MBA1, OXA1 
has the characteristics of a membrane-spanning protein, and 
homologues have been found in the plasma membrane of 
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bacteria [21]. As the protease function of Afg3p is not re- 
quired for mitochondrial biogenesis [4], suppression of afg3- 
null by MBA1 and OXA1 is not likely to be mediated by 
stimulation of protein degradation. Rather, they appear to 
bypass the role of Afg3p in complex assembly. 
The suppression of afg3- and rcal-null by MBA1 and 
OXA1, together with the fact that mutations in AFG3, 
RCA1, MBA1 and OXA1 all result in reduced assembly of 
several inner membrane nzyme complexes, and the likelihood 
that all encode proteins that are themselves associated with 
the inner membrane, suggests that these genes co-operate in 
the biogenesis of inner membrane complexes. 
B 
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Fig. 4. Mbal-cmyc localizes to the matrix side of the mitochondrial 
inner membrane. Mitochondria from wild-type strain W303/1A 
transformed with pC-MBAcmyc (C) or pE-MBAcmyc (E) were iso- 
lated and fractionated as described in Section 2. Samples were sepa- 
rated on 15% SDS-polyacrylamide g ls, blotted and probed with 
antibodies. A: Detection of Mbal-cmyc in the mitochondrial frac- 
tion. Mbal-cmyc expressed from low copy plasmid pC-MBAcmyc 
was only detected when applying five times the standard amount of 
protein to the gel (375 txg instead of 75 ktg; top right panel). Anti- 
bodies against hexokinase (Hex) and the major ADP/ATP carrier of 
the inner membrane (AAC) mark the cytoplasmic and mitochon- 
drial fraction of pE-MBAlcmyc transformed cells, respectively. B: 
Mitochondria were fractionated into membrane (p) and soluble (s) 
fractions either by sonication (son.) in the absence or presence of 
1 M NaC1, or by carbonate xtraction (CO32-). FI[~: blot probed 
with antiserum raised against he ~-subunit of F1-ATPase. C: De- 
tection of Mbal-cmyc and AAC in mitoplasts after incubation with 
(+) or without ( - )  proteinase K. As a control for the sensitivity of 
Mbal-cmyc towards proteinase K, mitoplasts were sonicated after 
addition of proteinase K and prior to incubation (son.), allowing 
proteolysis of proteins present in the matrix. 
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